AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
AerSale CorporationNASDAQ: ASLE
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $6.16M rose 23.2% year over year, ahead of the +12.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 13.2% from the prior quarter. Over 3 fiscal years it compounded at +20.7% a year.
Context
- Depreciation & amortization amounted to 5.8% of revenue in FY2025, up 1.0 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +23.2% holds above the trailing-twelve-month pace of +12.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 19.33M USD
- Year-over-year change
- +17.8%
- 4-year CAGR
- +10.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.33M | +17.8% |
| FY2024 | 2024-12-31 | 16.41M | +51.7% |
| FY2023 | 2023-12-31 | 10.82M | -1.5% |
| FY2022 | 2022-12-31 | 10.98M | -15.5% |
| FY2021 | 2021-12-31 | 13M | — |
Depreciation & Amortization vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's LTM Mar 2026 depreciation & amortization of $20.89M is the 6th highest of the 11 companies compared; the peer median is $18.26M.
- Its year-over-year change of +12.4% is the 4th highest of 11, against a peer median of -0.4%.
- Depreciation & amortization amounts to 6.1% of revenue for ASLE, versus a peer median of 5.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $62.3M | -1.3% | -0.4% | 2.8% | |
| LTM Apr 2026 | $52.56M | -5.4% | -4.4% | 12.8% | |
| LTM Mar 2026 | $42.75M | +13.1% | +12.1% | 7.7% | |
| LTM Mar 2026 | $29.2M | +2.9% | — | 20.3% | |
| LTM Mar 2026 | $22M | -15.6% | +0.7% | 5.7% | |
| LTM Mar 2026 | $20.89M | +12.4% | +20.7% | 6.1% | |
| LTM Mar 2026 | $14.52M | -37.8% | -9.2% | 22.9% | |
| LTM Mar 2026 | $7.95M | +27.7% | +8.7% | 1.8% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $2.69M | -21.0% | -23.2% | 1.6% |
| LTM Mar 2026 | $1.86M | +0.5% | +17.9% | 2.5% | |
| LTM Mar 2026 | $36.49K | +20.6% | +19.7% | — | |
| Peer median (excluding ASLE) | $18.26M | -0.4% | +0.7% | 5.7% | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 340.44M | 408.54M | 334.5M | 345.07M | 335.29M |
| Cost of Revenue | 221.05M | 257.15M | 242.08M | 241.13M | 229.51M |
| Gross Profit | 119.39M | 151.39M | 92.42M | 103.94M | 105.77M |
| Gross Margin | 35.1% | 37.1% | 27.6% | 30.1% | 31.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 77.5M | 96.35M | 103.19M | 94.19M | 89.98M |
| Operating Expenses | 62.73M | 96.35M | 103.19M | 94.19M | 89.98M |
| Depreciation & Amortization | 13M | 10.98M | 10.82M | 16.41M | 19.33M |
| EBITDA | 61.75M | 66.89M | 3.14M | 29.95M | 38.19M |
| EBITDA Margin | 18.1% | 16.4% | 0.9% | 8.7% | 11.4% |
| Operating Income | 56.66M | 55.05M | (10.77M) | 9.74M | 15.79M |
| Operating Margin | 16.6% | 13.5% | -3.2% | 2.8% | 4.7% |
| Interest Income | 0 | 0 | 155K | 0 | 0 |
| Interest Expense | 980K | 0 | 0 | 5.7M | 8.33M |
| Other Income / Expenses | (8.89M) | 2.84M | 3.09M | (1.91M) | (5.26M) |
| Income Before Tax | 47.77M | 57.88M | (7.68M) | 7.84M | 10.53M |
| Pre-Tax Margin | 14.0% | 14.2% | -2.3% | 2.3% | 3.1% |
| Income Tax Expense | 11.66M | 14.02M | (2.12M) | 1.99M | 1.95M |
| Net Income | 36.12M | 43.86M | (5.56M) | 5.85M | 8.58M |
| Net Margin | 10.6% | 10.7% | -1.7% | 1.7% | 2.6% |
| EPS (Basic) | 0.84 | 0.85 | (0.15) | 0.11 | 0.18 |
| EPS (Diluted) | 0.76 | 0.83 | (0.15) | 0.11 | 0.18 |
| Weighted Avg Shares | 43.19M | 51.57M | 51.29M | 53.11M | 47.2M |
| Weighted Avg Shares (Diluted) | 47.31M | 53.15M | 51.46M | 53.36M | 47.77M |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.